Table of Contents

December 01, 2002; Volume 69, Issue 12
  • From the Editor

      • Who is conducting the deadly quartet?

        Brian F. Mandell, MD
        • Cleveland Clinic Journal of Medicine December 2002, 69 (12) 927;
        • The metabolic syndrome warrants aggressive intervention and prevention, even if we cannot explain it yet.

  • Review

      • Emphysema in nonsmokers: Alpha 1-antitrypsin deficiency and other causes

        Pyng Lee, MD, Thomas R. Gildea, MD and James K. Stoller, MD, MS
        • Cleveland Clinic Journal of Medicine December 2002, 69 (12) 928-946;
        • The 10% of patients with emphysema who never smoked deserve a workup for its less common causes, including genetic risk modifiers and occupational exposures.

      • Update on the diagnosis and treatment of human papillomavirus infection

        Kristine M. Zanotti, MD and Jerome Belinson, MD
        • Cleveland Clinic Journal of Medicine December 2002, 69 (12) 948-961;
        • Genotyping can distinguish viral subtypes that pose a high risk for cancer, but current therapies do not reliably eradicate the virus, and warts and neoplasia often recur after treatment.

  • Interpreting Key Trials

      • The HIP trial

        Chad L. Deal, MD
        • Cleveland Clinic Journal of Medicine December 2002, 69 (12) 964-976;
        • Patients should be selected for bisphosphonate therapy on the basis of low bone density, not age.

  • Review

  • Editorial

  • Medical Grand Rounds

      • HIV update 2002

        Wendy Armstrong, MD, Leonard Calabrese, DO and Alan Taege, MD
        • Cleveland Clinic Journal of Medicine December 2002, 69 (12) 995-999;
        • “Treat early, treat hard” is changing to “treat a little later, treat hard.”

  • 1-Minute Consult

  • Departments